With Shkreli Out, KaloBios Asks for Appeal of Delisting by REUTERS

By REUTERS

KaloBios Pharmaceuticals said it had requested an appeal of Nasdaq’s decision to delist its shares.

Published: December 30, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1Toizbc

from WordPress http://ift.tt/1ICcffU
via Hadi Aboukhater